According to Xencor's latest financial reports the company's total liabilities are $0.28 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $0.28 B | 138.75% |
2022-12-31 | $0.11 B | 13.43% |
2021-12-31 | $0.10 B | -19.95% |
2020-12-31 | $0.13 B | 69.76% |
2019-12-31 | $77.04 M | 39.96% |
2018-12-31 | $55.05 M | -25.34% |
2017-12-31 | $73.73 M | -35.66% |
2016-12-31 | $0.11 B | 157.68% |
2015-12-31 | $44.47 M | 421.25% |
2014-12-31 | $8.53 M | -38.09% |
2013-12-31 | $13.78 M | -55.77% |
2012-12-31 | $31.16 M | -6.45% |
2011-12-31 | $33.31 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $98.78 B | 34,737.19% | ๐บ๐ธ USA |
AbbVie ABBV | $124.31 B | 43,740.61% | ๐บ๐ธ USA |
Amgen AMGN | $90.92 B | 31,964.58% | ๐บ๐ธ USA |
Merck MRK | $69.04 B | 24,247.67% | ๐บ๐ธ USA |
Seagen
SGEN | $1.08 B | 282.23% | ๐บ๐ธ USA |
MacroGenics MGNX | $0.14 B | -48.58% | ๐บ๐ธ USA |